Computational Modeling of Hippocampus in Schizophrenia

精神分裂症海马的计算模型

基本信息

  • 批准号:
    7317502
  • 负责人:
  • 金额:
    $ 17.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-08-21 至 2012-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): While researchers have learned vast amounts about brain function at a cellular and molecular level over the past several years, we still have a poor understanding of the manner in which these phenomena give rise to behavior, and the way that neurobiological dysfunction creates psychiatric symptoms. This is particularly true for schizophrenia: while a large number of research studies have implicated hippocampus in the etiology of schizophrenia, and several possible neuroanatomic and biochemical abnormalities have been identified in this region, we still do not know how these findings, alone or in combination, lead to the clinical syndrome. Computational modeling is a research tool that allows one to make links between cellular phenomena and clinical behaviors by offering insights at the level of cells or cell ensembles as to how emergent properties arise. We have developed a computer simulation of a subsection of hippocampus CA1 incorporating 452 cells. Each cell is a biologically realistic model of a neuron, featuring an extensive dendritic arborization and Na+, Ca++, K+DR, K*AHp, K+c, and K+A channels, as well as AMPA, NMDA, and GABA synapses. We will use an elaborated version of this computational model as a tool to examine particular hypothesis regarding the hippocampal neuropathology of schizophrenia. Specifically, we will "lesion" the model in a schizophrenogenic way by separately and in combination (a) altering aspects of the GABA system, (b) disrupting the glutamatergic system, and (c) increasing dopaminergic tone. We will examine two outcome measures: oscillatory activity and performance on context-dependent memory tasks; both of these have clinical correlations with schizophrenia. Finally, we will apply a number medications, including typical and atypical antipsychotics, and examine their effects on system functioning. We expect these studies to 1) offer mechanistic and system-level insights into the neuropathological basis of the illness; 2) generate hypotheses that can subsequently be tested experimentally; and 3) identify potentially effective antipsychotic medications. Also, we hope that this study can make a contribution from a methodological point of view: though it involves only one brain area performing a discrete psychological task for a particular psychiatric illness, it is an approach that potentially can be applied to other brain regions and neuropsychiatric diseases.
描述(由申请人提供):虽然研究人员在过去几年中已经在细胞和分子水平上了解了大量关于大脑功能的知识,但我们仍然对这些现象引起行为的方式以及神经生物学功能障碍产生精神症状的方式缺乏了解。这对于精神分裂症尤其如此:虽然大量的研究表明海马体与精神分裂症的病因有关,并且在该区域已经确定了几种可能的神经解剖学和生化异常,但我们仍然不知道这些发现如何单独或组合导致临床综合征。计算建模是一种研究工具,它允许人们通过在细胞或细胞系综水平上提供关于涌现特性如何产生的见解,在细胞现象和临床行为之间建立联系。我们已经开发了一个计算机模拟的海马CA 1区纳入452个细胞的一个分区。每个细胞都是神经元的生物学真实模型,具有广泛的树突状分支和Na+、Ca++、K+DR、K*AHp、K+c和K+A通道,以及AMPA、NMDA和GABA突触。我们将使用一个详细的版本,这个计算模型作为一种工具,以检查特定的假设,关于海马神经病理学的精神分裂症。具体而言,我们将通过单独或联合(a)改变GABA系统的各个方面,(B)破坏多巴胺能系统,(c)增加多巴胺能张力,以致肾上腺皮质激素的方式“损伤”模型。我们将研究两个结果的措施:振荡活动和上下文相关的记忆任务的性能,这两个与精神分裂症的临床相关性。最后,我们将应用一些药物,包括典型和非典型的抗精神病药物,并检查它们对系统功能的影响。我们期望这些研究1)提供对疾病神经病理学基础的机制和系统水平的见解; 2)产生随后可以通过实验验证的假设; 3)确定潜在有效的抗精神病药物。此外,我们希望这项研究可以从方法论的角度做出贡献:虽然它只涉及一个大脑区域执行特定精神疾病的离散心理任务,但它是一种可能适用于其他大脑区域和神经精神疾病的方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PETER JOHN SIEKMEIER其他文献

PETER JOHN SIEKMEIER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PETER JOHN SIEKMEIER', 18)}}的其他基金

Computational Modeling of Hippocampus in Schizophrenia
精神分裂症海马的计算模型
  • 批准号:
    8054314
  • 财政年份:
    2007
  • 资助金额:
    $ 17.28万
  • 项目类别:
Computational Modeling of Hippocampus in Schizophrenia
精神分裂症海马的计算模型
  • 批准号:
    7487297
  • 财政年份:
    2007
  • 资助金额:
    $ 17.28万
  • 项目类别:
Computational Modeling of Hippocampus in Schizophrenia
精神分裂症海马的计算模型
  • 批准号:
    7803631
  • 财政年份:
    2007
  • 资助金额:
    $ 17.28万
  • 项目类别:
Computational Modeling of Hippocampus in Schizophrenia
精神分裂症海马的计算模型
  • 批准号:
    7609102
  • 财政年份:
    2007
  • 资助金额:
    $ 17.28万
  • 项目类别:

相似海外基金

Drug Interactions Involving Second-generation Antipsychotic Agents Leading to Sudden Cardiac Arrest
涉及第二代抗精神病药物的药物相互作用导致心脏骤停
  • 批准号:
    10661090
  • 财政年份:
    2022
  • 资助金额:
    $ 17.28万
  • 项目类别:
Drug Interactions Involving Second-generation Antipsychotic Agents Leading to Sudden Cardiac Arrest
涉及第二代抗精神病药物的药物相互作用导致心脏骤停
  • 批准号:
    10501196
  • 财政年份:
    2022
  • 资助金额:
    $ 17.28万
  • 项目类别:
Possible mechanism of action of metabolic syndrome induction in patients treated with atypical antipsychotic agents
使用非典型抗精神病药物治疗的患者诱导代谢综合征的可能作用机制
  • 批准号:
    22590157
  • 财政年份:
    2010
  • 资助金额:
    $ 17.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The use of atypical antipsychotic agents and the risk of breast cancer
非典型抗精神病药物的使用和乳腺癌的风险
  • 批准号:
    192724
  • 财政年份:
    2009
  • 资助金额:
    $ 17.28万
  • 项目类别:
    Operating Grants
Indolobenzox- and Thiazepines as Atypical Antipsychotic Agents
吲哚苯氧和硫氮卓类药物作为非典型抗精神病药
  • 批准号:
    7539253
  • 财政年份:
    2008
  • 资助金额:
    $ 17.28万
  • 项目类别:
Ectopic activators of M1 as novel antipsychotic agents
M1 异位激活剂作为新型抗精神病药物
  • 批准号:
    7676049
  • 财政年份:
    2007
  • 资助金额:
    $ 17.28万
  • 项目类别:
Ectopic activators of M1 as novel antipsychotic agents
M1 异位激活剂作为新型抗精神病药物
  • 批准号:
    7626881
  • 财政年份:
    2007
  • 资助金额:
    $ 17.28万
  • 项目类别:
Ectopic activators of M1 as novel antipsychotic agents
M1 异位激活剂作为新型抗精神病药物
  • 批准号:
    7333930
  • 财政年份:
    2007
  • 资助金额:
    $ 17.28万
  • 项目类别:
Muscarinic receptor activators as antipsychotic agents
作为抗精神病药物的毒蕈碱受体激活剂
  • 批准号:
    7034693
  • 财政年份:
    2006
  • 资助金额:
    $ 17.28万
  • 项目类别:
Muscarinic receptor activators as antipsychotic agents
作为抗精神病药物的毒蕈碱受体激活剂
  • 批准号:
    8391749
  • 财政年份:
    2006
  • 资助金额:
    $ 17.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了